Skip to main content

Cost modelling rehabilitation in the home for reconditioning in the Australian context

Abstract

Background

Inpatient rehabilitation services are challenged by increasing demand. Where appropriate, a shift in service models towards more community-oriented approaches may improve efficiency. We aimed to estimate the hypothetical cost of delivering a consensus-based rehabilitation in the home (RITH) model as hospital substitution for patients requiring reconditioning following medical illness, surgery or treatment for cancer, compared to the cost of inpatient rehabilitation.

Methods

Data were drawn from the following sources: the results of a Delphi survey with health professionals working in the field of rehabilitation in Australia; publicly available data and reports; and the expert opinion of the project team. Delphi survey data were analysed descriptively. The costing model was developed using assumptions based on the sources described above and was restricted to the Australian National Subacute and Non-Acute Patient Classification (AN-SNAP) classes 4AR1 to 4AR4, which comprise around 73% of all reconditioning episodes in Australia. RITH cost modelling estimates were compared to the known cost of inpatient rehabilitation. Where weighted averages are provided, these were determined based on the modelled number of inpatient reconditioning episodes per annum that might be substitutable by RITH.

Results

The cost modelling estimated the weighted average cost of a RITH reconditioning episode (which mirrors an inpatient reconditioning episode in intensity and duration) for AN-SNAP classes 4AR1 to 4AR4, to be A$11,371, which is 28.1% less than the equivalent weighted average public inpatient cost (of A$15,820). This represents hypothetical savings of A$4,449 per RITH reconditioning substituted episode of care.

Conclusions

The hypothetical cost of a model of RITH which would provide patients with as comprehensive a rehabilitation service as received in inpatient rehabilitation, has been determined. Findings suggest potential cost savings to the public hospital sector. Future research should focus on trials which compare actual clinical and cost outcomes of RITH for patients in the reconditioning impairment category, to inpatient rehabilitation.

Peer Review reports

Background

Rehabilitation for ‘reconditioning’ is defined as rehabilitation for ‘generalised deconditioning not attributable to any of the other impairment groups’ such as stroke, neurological conditions, and cardiac, orthopaedic or pain disorders (see Australasian Rehabilitation Outcomes Centre (AROC) impairment codes 16.1, 16.2 and 16.3 [1]). It is the largest (approximately 26% [2]) inpatient rehabilitation impairment type in Australia, and the number of episodes of reconditioning rehabilitation has doubled in a decade, increasing from 16,120 episodes in 2010 [3] to 32,877 in 2019 [4].

Inpatient rehabilitation units in both the public and private hospital sectors, are mostly working to capacity [5] and are challenged by increasing demand [6, 7]. One Australian study found that overall, patients requiring rehabilitation spent time equivalent to 12% of their acute hospital length of stay waiting for a rehabilitation bed [8]. Furthermore, the COVID-19 pandemic resulted in additional challenges for rehabilitation, including a reduction in available bed capacity and pressure for earlier patient discharge [9]. Rehabilitation patients may also be particularly vulnerable to COVID-19 due to their multiple comorbidities and/or older age, and opportunities for exposure and transmission of the virus occurring during therapy in common areas [10]. Thus, calls for shifting service models towards more community-oriented approaches are being made, both for improved efficiency and in the context of responding to COVID-19 [9].

Home-based rehabilitation as hospital substitution for stroke and orthopaedic conditions has been well described in the literature, with reports of comparable or better outcomes for appropriate patients compared to usual inpatient care (e.g., [11,12,13,14,15]). Further, systematic reviews of stroke trials [16, 17], and an individual trial of unilateral total hip or knee replacement [17] suggest that the costs are lower for home-based rehabilitation compared to usual inpatient rehabilitation. However, there is little research addressing rehabilitation in the home (RITH) for patients with generalised deconditioning, a group with substantial heterogeneity.

Thus, we sought to establish consensus on a model for RITH as hospital substitution for patients requiring reconditioning, through a three-round Delphi on-line survey with a multidisciplinary group of Australian health professionals working in the rehabilitation field. This research was undertaken during 2021/22, and was led by a multidisciplinary project team, consisting of academics (n = 4), rehabilitation physicians (n = 6), an occupational therapist (n = 1), and a health service financing consultant (n = 1). In summary, the first Delphi survey round was developed by the project team drawing on their combined expertise from working and researching in the rehabilitation setting, and informed by a rapid review of the literature on home-based rehabilitation services. Subsequent survey rounds explored issues for which consensus had not been achieved in a previous round, or tested issues that participants had raised in free text boxes. Survey methodology, individual survey items reaching consensus and the consensus model are reported in detail elsewhere [18]. Consensus was achieved on over 130 statements, leading to the development of a RITH for reconditioning model which consisted of five key steps aligned to the patient journey. The steps in the model were: initial patient identification; determination of eligibility and acceptance onto RITH; care plan development; program delivery; and discharge from RITH. Additional items related to the model covered clinical governance and budgetary considerations [18].

This paper estimates the hypothetical cost of providing the consensus-based model of RITH, where RITH mirrors an inpatient episode in intensity and duration. It also presents comparative cost estimates for RITH and inpatient rehabilitation for reconditioning and discusses the potential impact of RITH for reconditioning on aggregate public hospital rehabilitation expenditure.

Methods

Cost modelling for RITH for reconditioning was undertaken utilising the following sources: Delphi survey consensus statements that related to the content or cost of a RITH program, and which have been reported previously [18]; publicly available data (population and inpatient rehabilitation statistics) and reports including Australian rehabilitation service standards and other documents that reported the content of inpatient rehabilitation and RITH for reconditioning or similar programs (referenced as appropriate in the Tables and text); and the expert opinion of the project team [18], who reviewed, discussed, and agreed upon the underlying model assumptions over the course of numerous research team meetings.

We also used the results of two questions which were developed for the third and final Delphi survey round to test the potential utilisation of RITH. A subset of the project team (n = 4) developed the questions, which were then tested and refined with the remainder (n = 8) of the team, before being included in the survey. The questions asked participants to use their clinical knowledge to estimate the potential utilisation of RITH for each of the six reconditioning case-mix classes used in Australia (Australian National Subacute and Non-Acute Patient classification (AN-SNAP) classes 4AR1 through 4AR6 [1]). Participants were asked two questions: ‘What percentage of reconditioning patients in the following AN-SNAP classes do you think are likely to be suitable for RITH?’ followed by ´What percentage of suitable reconditioning patients would you expect to actually want to take part in a RITH program if one were available?’. Responses for each AN-SNAP class (4AR1 through 4AR6) were made using a slider which could be moved on a scale from zero to 100 percent. Participants who felt they had insufficient clinical familiarity with AN-SNAP classifications to answer the questions were asked to opt out from these, leaving only a subset of respondents.

Data analysis

Descriptive analysis of Delphi data was undertaken using SPSS V27. Each Delphi participant’s estimated potential utilisation of RITH (by AN-SNAP class) was calculated from their estimate of the percentage of reconditioning patients suitable for RITH, multiplied by their estimate of the percentage of suitable reconditioning patients who might wish to take part in RITH if available. The median estimates for each class were determined.

Cost modelling was developed in MS Excel (Office 365) and was restricted to reconditioning classes 4AR1 to 4AR4. RITH program costs per episode were determined (Tables 3 and 4) and compared to the known inpatient cost per episode (Table 5). The assumptions and information sources underlying the calculations are detailed within each Table. Weighted averages for each metric in Tables 3, 4 and 5 were also determined, based on the modelled number of substitutable episodes per annum. The modelled number of substitutable episodes per annum is the number of inpatient reconditioning rehabilitation episodes that might be able to be substituted by RITH, limited to capital cities, and is based on the AN-SNAP reconditioning episodes reported to AROC in the 2019 (the last pre-Covid) year [2], adjusted for the potential utilisation of RITH determined from the Delphi survey (Table 2). The choice to limit the estimate to capital cities is conservative, since it assumes the operational efficiency available to RITH providers which arises from greater population density, may not be available elsewhere. Details of the calculations to determine the modelled number of substitutable episodes are shown in detail in Additional File 1.

Results

Delphi survey consensus statements relevant to the cost model

As previously reported, over 130 statements on aspects of the patient journey achieved consensus (that is, at least 70% of participants agreed/strongly agreed) during the Delphi survey [18]. The subset of these statements that were considered by the project team to have the most direct impact on the cost modelling for RITH are shown in Table 1. These statements relate to staff, program features and budgetary factors, and will be referred to in the text as T1.Item No.

Table 1 The subset of Delphi survey consensus statements that had the most direct impact on the cost model [18]

Estimated potential utilisation of RITH for reconditioning from the Delphi survey

Twenty-one participants (of 78 participating in the third Delphi survey round) indicated clinical familiarity with the AN-SNAP classification and responded to the questions relating to potential RITH utilisation. These were rehabilitation medicine physicians (n = 9, 42.9%), rehabilitation nurses (n = 6, 28.6%), physiotherapists (n = 3, 14.3%) and occupational therapists (n = 3, 14.3%). They estimated that around half of all patients in the higher functioning classes (AN-SNAP classes 4AR1 and 4AR2) may utilise RITH if it were available, but that few patients in the lowest functioning classes (AN-SNAP classes 4AR5 and 4AR6) would likely do so. See Table 2.

Table 2 Estimated potential utilisation of RITH by AN-SNAP class (n = 21 participants)

Costing the RITH episode

The underlying assumption was that RITH should provide as comprehensive a rehabilitation service as would be provided by inpatient rehabilitation and be no more costly than inpatient rehabilitation (T1.15; T1.17). Cost modelling was restricted to the provision of RITH for patients in AN-SNAP classes 4AR1 to 4AR4 (which comprise around 73% of all inpatient reconditioning episodes in Australia [4]), as these were groups for whom Delphi survey participants estimated the potential utilisation would be greatest (Table 2).

Staff input

Table 3 shows the estimated staff input (occasions of service (OOS) per episode) required for RITH for reconditioning, drawing on T1.1 – T1.8 and T1.11. The specific information sources and assumptions underlying the estimates are shown in the right-hand column of Table 3. For allied health, clinical case manager, and rehabilitation nurse, the project team deemed each OOS as being 60 min with the patient, plus 30 min of preparation and documentation time, plus 40 min of travel time (130 min in total per OOS). On a weekly basis, this translates to:

  • Twelve allied health OOS per week;

  • Two clinical case manager therapeutic OOS per week. The clinical case manager could be either an allied health practitioner or a rehabilitation nurse (depending on patient need); and

  • One rehabilitation nurse OOS per week.

Table 3 Estimated staff input for RITH for reconditioning programs

For the rehabilitation physician,

  • One OOS (via telehealth, T1.16) is provided per week. Each OOS was deemed to be 45 min, plus an additional 30 min of preparation, documentation and medical correspondence time (75 min in total). No junior medical officer support for RITH has been assumed in this cost model.

There is also allowance for:

  • Two clinical case manager planning sessions per week. For consistency, each planning session is termed an OOS and was deemed to be 120 min.

  • One case conference (T1.14) per week with five staff, and daily multi-disciplinary team (MDT) huddles (quick meetings which focus on each patient’s progression towards discharge) [23] as detailed in Table 3.

RITH program costs per episode

Table 4 shows the associated cost (in Australian dollars) of staff and other inputs required for RITH reconditioning episodes, along with the specific information sources and assumptions underlying the estimates presented. RITH program costs per episode are shown both by clinician type and by service type. Additional program costs include travel reimbursement (for staff use of own vehicles), home support services (e.g., meals, personal care assistance, T1.18, T1.19), and equipment depreciation (assuming an equipment loan pool for RITH patients of A$200,000).

Table 4 RITH program costs per episode (A$)

The estimated hypothetical cost per RITH reconditioning episode ranges from A$9,817 (4AR1), to A$15,491 (4AR4), with a weighted average cost per episode of A$11,371. The weighted average RITH episode cost can be broken down into the following components:

  • A$3,143 (27.6% of total) in direct patient servicing time costs;

  • A$1,885 (16.6% of total) in staff travel time costs;

  • A$794 (7.0% of total) in staff case conferencing and MDT huddle costs;

  • A$2,381 (20.9% of total) in case management and planning costs;

  • A$40 (0.3% of total) administrative support for client intake;

  • A$1,634 (14.4% of total) in corporate overhead costs;

  • A$654 (5.8% of total) in travel reimbursement costs;

  • A$678 (6.0% of total) in-home support costs;

  • A$145 (1.3% of total) in consumables costs;

  • A$16 (0.1% of total) in equipment depreciation costs.

RITH episode cost compared to that of inpatient rehabilitation

Table 5 estimates the potential cost savings per episode to the public hospital sector in Australia of the proposed RITH program compared to inpatient rehabilitation for reconditioning. The weighted average public inpatient cost per episode of A$15,820 has been estimated with reference to publicly available Independent Health and Aged Care Pricing Authority (IHACPA) data points. Each AN-SNAP class has an IHACPA associated cost weight (ranging from 2.3 for 4AR1 to 4.11 for 4AR4) ([22], p.84) and the IHACPA National Efficient Price per single cost weight of activity in 2021–22 was A$5,597 ([22], p.7). Thus, the derived price paid for an inpatient reconditioning episode in this period ranges from A$12,850 for 4AR1 to A$22,976 for 4AR4 (weighted average of A$15,820). The modelled RITH costs (calculations shown in Table 4 and reappearing in Table 5) indicate hypothetical savings per episode ranging from 23.6% for 4AR1, to 32.6% for 4AR4 (weighted average of 28.1%).

Table 5 Potential cost savings to the public hospital sector (A$)

A conservative estimate of the potential impact of RITH for reconditioning on aggregate public hospital rehabilitation expenditure in Australia

A conservative estimate of potential cost savings to the Australian public hospital sector was quantified, using the modelled number of substitutable episodes per annum. Details on the derivation of the number of substitutable episodes are provided in Additional File 1. In summary, they relate to the provision of RITH in the capital city only [28] of each state or territory, and use the estimated potential utilisation of RITH for reconditioning for the four AN-SNAP classes 4AR1 through 4AR4 (Table 2), and the number of reconditioning episodes (4AR1 to 4AR4) reported to AROC in the 2019 year ([2], p. 92). Based on the above, an estimated 2,459 public inpatient reconditioning rehabilitation episodes could be substituted with a RITH program annually. The project team restricted the estimate to capital cities because the greater population density in these cities would allow RITH service providers operational efficiencies from having critical mass. This is a conservative approach since other large Australian cities may offer similar efficiencies. RITH in regional and rural locations, however, might require a greater allowance for staff travel costs.

Should 2,459 public inpatient reconditioning rehabilitation episodes be substituted with RITH, this would translate into hypothetical cost savings to government of A$10.9 million dollars annually (Table 5).

Discussion

In this paper, costings of a consensus-based model for RITH as hospital substitution for patients requiring reconditioning (in AN-SNAP classes 4AR1 to 4AR4) have been presented, drawing on Delphi survey data [18], publicly available data, relevant reports and rehabilitation standards, and informed by the clinical and service experience of the research team. Costings have been applied to a RITH for reconditioning model which reflects an equivalent public hospital inpatient rehabilitation episode in terms of duration and intensity, with significant hypothetical cost savings per episode found for RITH when compared to inpatient rehabilitation.

RITH intensity and cost

We have attempted to present a fully costed RITH hospital substitution program. While the actual amount of therapy intensity for inpatient rehabilitation is not formally reported, the Australasian Faculty of Rehabilitation Medicine (AFRM) Standards recommend that therapy should consist of a minimum of three hours per day over five days per week for patients who can tolerate it ([19], p.10). Published data suggest that actual therapy levels may be less, especially for older patients who are not presenting with a predominantly neurological impairment [29]. Our modelled allied health therapy intensity is an average of 1.7 h/day over 7 days, which is equivalent to an average of 2.4 h per day over five days. This does not include nursing input or clinical case management time, both of which are likely to include a therapy component.

Our costing model provides a total of allied health therapy per RITH episode that ranges from 20.1 (4AR1) through to 31.7 (4AR4) hours, which increases to a total of 26.7 h (4AR1) to 42.3 h (4AR4) with the inclusion of other direct clinical input (i.e., therapy plus clinical case management, plus nursing, plus rehabilitation physician time). Data from the AROC Ambulatory Report [21] indicate the mean number of occasions of service per episode for patients with a reconditioning impairment code in Australia in 2021 was 26.4 ([21], p.32). If we assume that an OOS is one hour (since it is not defined by AROC), then this is supportive of our model. Direct comparison is difficult however, because the AROC ambulatory dataset includes patients whose rehabilitation may have only been in an ambulatory setting, as well as those for whom it may have been a continuation of the inpatient rehabilitation episode; and the extent to which AROC-reported episodes were ‘hospital substitution’ is unknown. Interestingly, the mean length of program for the reconditioning impairment code in the Report is 62.8 days ([21], p. 26), which suggests therapy in the ambulatory setting was spread over a long duration. This would be more akin to an alternative RITH service delivery model which Delphi survey participants also supported [18] on the assumption that it would be of lower or varied intensity, delivered over a duration of up to ten weeks, and cost-equivalent to the intensive, shorter duration model costed in this paper.

Our modelled cost per episode of RITH for reconditioning ranges from A$9,817 (4AR1) to A$15,491 (4AR4), with the estimated weighted average cost being A$11,371. While we were unable to locate any publicly available data on the cost of other RITH programs for reconditioning as hospital substitution, some comparative data are available for other programs delivered in the home. The Transition Care Program (TCP) and the Short-Term Restorative Care (STRC) Program are Australian government funded programs targeting community-dwelling older people who have experienced functional decline and who have (in the case of TCP) and have not (in the case of STRC) experienced recent hospitalisation [30]. These programs offer short term support (8 – 12 weeks) with low intensity therapy aimed at improving function and reducing premature admission to residential aged care. The duration of the TCP and STRC programs are more akin to the alternative RITH program described above (that is, lower or varied therapy intensity of up to 10 weeks duration) and the AROC reported average duration of ambulatory rehabilitation for reconditioning ([21], p. 26).

The cost to government of delivering an STRC program, which runs over a maximum of 56 days, was set at A$214.39 per day for 2021–2022 [31], equating to just over A$12,000 per 56-day episode, which is similar to our weighted average cost per RITH episode. The reported cost of delivering the TCP program (up to 12-weeks) varies between jurisdictions, ranging from A$247.34 per day in the ACT to A$348.68 per day in Victoria (2018 financial year) [32]. This would equate to between A$20,000 and A$30,000 per 12-week episode, thus considerably higher than our weighted average cost per RITH episode. This may be somewhat accounted for by the fact that the cost of TCP appears to increase as the proportion of episodes delivered in residential care increases, while our RITH model assumes delivery in the home setting only (Table 4). Further, TCP may provide additional nursing support and personal care to that which we have allowed within our costing of RITH.

Potential savings from RITH for reconditioning

We have shown hypothetical cost savings that range from 23.6% (4AR1) to 32.6% (4AR4) per episode (weighted average saving of 28.1%) compared to the cost of an inpatient rehabilitation program for reconditioning. Cost savings have been reported for existing RITH programs in other patient groups and for “non-rehabilitation” hospital-in-the home programs with partial or total episode substitution (e.g., [16, 17, 33,34,35,36]). For example, savings were found to range from 4%—30% for various stroke early supported discharge programs versus usual care [16], while an average saving of 26.5% [34] was reported in a meta-analysis of ‘hospital in the home’ studies, which suggest our estimated savings are credible.

The majority of our hypothetical cost savings of RITH for reconditioning over inpatient rehabilitation is likely accounted for by the absence of costs associated with 24/7 inpatient nursing care and hotel services. Counter to this saving is the requirement for staff to travel, which we estimated to be 22.4% of the cost of RITH (based on an allowance of 40 min travel per OOS plus a staff travel allowance of 90 cents per kilometre for use of their own vehicle, Table 4). Travel cost is a variable that will depend on several factors, comprising the location serviced (including distances to be travelled, traffic congestion, road tolls and parking costs) and economies of scale arising with patient volume. For these reasons we modelled the potential costs (and cost savings) for capital cities only. Some allowance for the provision of in-home support for patients and carers has been made (6.0% of program cost), but this could be increased depending on assessed patient need, while still remaining below the cost of an inpatient rehabilitation episode.

With good patient selection, we expect re-admission rates to acute care from RITH to be similar to those that occur for inpatient rehabilitation (T1.10, T1.13). However, we expect some patients (less than 10%, T1.9, T1.12) who undergo RITH to subsequently require inpatient rehabilitation. While this might dilute the savings, it is likely that patients who failed to adequately progress in RITH would have required a longer than average inpatient rehabilitation episode had they remained in a hospital rehabilitation ward, but we have no data available to support this assertion.

Impact on the patient and their household

When inpatient care is shifted to the home, informal carers are to a greater or lesser extent undertaking some of the care-work that would have previously been undertaken by paid staff [37]. As carers are integral to the success of RITH programs for many patients, carers must be fully informed, willing and supported [18, 37]. The provision of in-home support in our model was an attempt to reduce carer burden. There is a need for future research to measure costs associated with the carer role in order to understand fully the implications of RITH as hospital substitution [37]. Despite the potential cost and care-shift [37], patients and carers who had experienced RITH for neurological and orthopaedic conditions, found being at home beneficial for therapy and for the well-being of both the patient and their family [38]; thus for appropriate patients (and carers), RITH provides increased choice about care.

Potential aggregate savings to the public hospital sector

Our finding of potential aggregate public hospital system savings of A$10.9 million are based on a number of assumptions, including the estimated potential utilisation of RITH for reconditioning and the relative cost of inpatient rehabilitation versus our modelled RITH cost. Any such savings should be regarded as theoretical and imprecise for several reasons. First, estimated potential utilisation is based on the experience of a self-selected subset of survey participants and cannot be assumed to be generalisable (e.g., factors impacting patient selection may vary in different socio-demographic communities). Second, the uptake of RITH by individual health services may not be complete, and will vary depending on local factors (e.g., economies of scale that can be achieved, workforce availability, and competing service priorities). Third, ‘savings’ will only be achieved if inpatient rehabilitation bed utilisation is reduced, allowing actual savings to be realised.

In reality, ‘savings’ may better expressed as the delivery of greater capacity for the same overall system expenditure, leading to an alleviation of inpatient capacity constraints within the existing public hospital system. By extension, fewer additional inpatient beds may be required in the future, resulting in savings in both (a) capital expenditure (fewer beds needing to be built) and (b) recurring operational expenses (from the servicing of additional beds). Note that our modelling excludes any potential capital savings.

Strengths and further limitations

A detailed discussion of the limitations of the Delphi survey methodology used has been presented elsewhere [18]. In addition to the limitations listed in the preceding section, there are several other limitations associated with our cost modelling of RITH episodes which must be acknowledged. Of note, our estimates are hypothetical only, since an operating program was not costed. Some of the assumptions used in our costings have relied on the clinical and service expertise of the authors, due to the absence of other information sources. While this could present a source of bias, assumptions have been made explicit and transparent through the details provided in Tables 3, 4 and 5 and Additional File 1. It is possible that additional costs may be incurred while the patient is at home, that have not been accounted for in the model, such as medical investigations, pathology, and non-routine medical assessments (i.e., beyond the rehabilitation physician reviews). However, as per our admission criteria for RITH [18], patients should enter RITH medically stable (T1.10). Conversely, there may be opportunities for trimming and/or reallocating costs based on individual service configurations and overhead costs. Medical staffing configurations may include the use of junior medical staff to defray the amount of medical consultant time required. The transparency of our assumptions should enable such modifications to be made by readers. We must also acknowledge that the cost model is vulnerable to unpredictable costs, such as higher readmission rates and poorer clinical outcomes (e.g., falls at home). On the other hand, calculated public hospital sector ‘savings’ have been limited to RITH in capital cities only, thus are potentially conservative.

The number of inpatient reconditioning episodes relied on 2019 data, because of the impact of the COVID-19 pandemic on rehabilitation admissions during 2020—2022 [9]. Further, no adjustment to capital city numbers was made for the small proportion of inpatient episodes involving people in AN-SNAP classes 4AR1 to 4AR4 who were domiciled in residential care prior to the onset of their impairment (< 2%) [4]. While RITH for patients from a residential care facility was outside the scope of this project, the authors are of the view that viable RITH models could be developed for patients returning to residential care for rehabilitation following an acute hospital episode. In this paper we have only presented modelling for the cost of RITH that mirrors an inpatient rehabilitation episode in the public hospital sector. We did not model the cost of the second RITH program delivery model that was supported by Delphi survey participants (i.e. RITH of longer duration and of lesser or variable intensity) [18], but we assume it should be roughly cost equivalent.

Conclusions

The hypothetical cost of a model of RITH which would provide patients with as comprehensive a rehabilitation service as received in inpatient rehabilitation has been determined, with costing assumptions provided. If programs can be delivered that provide comparable clinical outcomes to those in inpatient rehabilitation, then RITH for the reconditioning impairment category has the potential to assist with Australia’s growing demand for reconditioning following acute hospitalisation, to offer an alternative to inpatient rehabilitation for appropriate patients, and to allow greater system capacity for the same overall expenditure. Future research should focus on trials which compare actual clinical and cost outcomes for RITH, to inpatient rehabilitation.

Availability of data and materials

The data generated and analysed during the current study are available from the corresponding author on reasonable request and pending ethics committee approval.

Abbreviations

AFRM:

Australasian Faculty of Rehabilitation Medicine

ALOS:

Average length of stay

AN-SNAP:

Australian National Subacute and Non-Acute Patient

AROC:

Australasian Rehabilitation Outcomes Centre

FIM:

Functional Independence Measure

MDT:

Multi-disciplinary team

OOS:

Occasion of service

RITH:

Rehabilitation in the home

References

  1. Australasian Rehabilitation Outcomes Centre (AROC). AROC impairment coding guidelines: AROC and Australian Health Services Research Institute; 2013. Available from: https://documents.uow.edu.au/content/groups/public/@web/@chsd/@aroc/documents/doc/uow125260.pdf. 19 July 2022.

  2. Australasian Rehabilitation Outcomes Centre (AROC). AROC Annual Report – The state of inpatient rehabilitation in Australia in 2019 Australasian Rehabilitation Outcomes Centre, Australian Health Services Research Institute, University of Wollongong; 2020. Available from: https://ro.uow.edu.au/cgi/viewcontent.cgi?article=2131&context=ahsri. 28 June 2022.

  3. Australasian Rehabilitation Outcomes Centre (AROC). AROC Annual Report – The state of inpatient rehabilitation in Australia in 2010: Australasian Rehabilitation Outcomes Centre, Australian Health Services Research Institute, University of Wollongong; 2010. Available from: https://documents.uow.edu.au/content/groups/public/@web/@chsd/@aroc/documents/doc/uow106153.pdf. 3 July 2022.

  4. Australasian Rehabilitation Outcomes Centre (AROC). Impairment Specific Report on Reconditioning (Calendar Year 2019): Australasian Rehabilitation Outcomes Centre, Australian Health Services Research Institute, University of Wollongong; 2020. Available from: https://documents.uow.edu.au/content/groups/public/@web/@chsd/@aroc/documents/doc/uow263782.pdf. 6 June 2022.

  5. NSW Agency for Clinical Innovation. Principles of rehabilitation: A response to COVID-19 surge escalation2020 13 December 2022]. Available from: https://www.health.nsw.gov.au/Infectious/covid-19/communities-of-practice/Documents/guide-principles-rehabilitation.pdf.

  6. New PW, Poulos CJ. Functional improvement of the Australian health care system - can rehabilitation assist? Med J Aust. 2008;189(6):340–3.

    Article  PubMed  Google Scholar 

  7. Poulos CJ, Magee C, Bashford G, Eagar K. Determining level of care appropriateness in the patient journey from acute care to rehabilitation. BMC Health Serv Res. 2011;11:291.

    Article  PubMed  PubMed Central  Google Scholar 

  8. New PW, Andrianopoulos N, Cameron PA, Olver JH, Stoelwinder JU. Reducing the length of stay for acute hospital patients needing admission into inpatient rehabilitation: a multicentre study of process barriers. Intern Med J. 2013;43(9):1005–11.

    Article  CAS  PubMed  Google Scholar 

  9. Kuipers P FJ, Gavaghan B, Farrow E, McBride L, Foster M. Informing COVID service responses that impact on rehabilitation care. Deeble Perspectives Brief 22.2022. Available from: https://ahha.asn.au/sites/default/files/docs/policy-issue/perspectives_brief_no_22._informing_covid_service_responses.pdf.

  10. Jow S, Doshi S, Desale S, Malmut L. Mental health impact of COVID-19 pandemic on therapists at an inpatient rehabilitation facility. PM&R. 2023;15(2):168–75.

    Article  Google Scholar 

  11. Rasmussen RS, Østergaard A, Kjær P, Skerris A, Skou C, Christoffersen J, et al. Stroke rehabilitation at home before and after discharge reduced disability and improved quality of life: a randomised controlled trial. Clin Rehabil. 2016;30(3):225–36.

    Article  PubMed  Google Scholar 

  12. Crotty M, Whitehead CH, Gray S, Finucane PM. Early discharge and home rehabilitation after hip fracture achieves functional improvements: a randomized controlled trial. Clin Rehabil. 2002;16(4):406–13.

    Article  PubMed  Google Scholar 

  13. Mahomed NN, Davis AM, Hawker G, Badley E, Davey JR, Syed KA, et al. Inpatient compared with home-based rehabilitation following primary unilateral total hip or knee replacement: a randomized controlled trial. J Bone Joint Surg Am. 2008;90(8):1673–80.

    Article  PubMed  Google Scholar 

  14. Karlsson Å, Lindelöf N, Olofsson B, Berggren M, Gustafson Y, Nordström P, et al. Effects of geriatric interdisciplinary home rehabilitation on independence in activities of daily living in older people with hip fracture: a randomized controlled trial. Arch Phys Med Rehabil. 2020;101(4):571–8.

    Article  PubMed  Google Scholar 

  15. Lee M-C, Chang C-W, Shih S-L, Huang S-J, Tsauo J-Y, Hsiao K-L, et al. Efficacy and cost-effectiveness analysis of post-acute care for elderly patients with hip fractures. J Formos Med Assoc. 2022;121(8):1596–604.

    Article  PubMed  Google Scholar 

  16. Brady BK, McGahan L, Skidmore B. Systematic review of economic evidence on stroke rehabilitation services. Int J Technol Assess Health Care. 2005;21(1):15–21.

    Article  PubMed  Google Scholar 

  17. Brusco NK, Taylor NF, Watts JJ, Shields N. Economic evaluation of adult rehabilitation: a systematic review and meta-analysis of randomized controlled trials in a variety of settings. Arch Phys Med Rehabil. 2014;95(1):94-116.e4.

    Article  PubMed  Google Scholar 

  18. Poulos RG, Cole AM, Warner KN, Faux SG, Nguyen TA, Kohler F, et al. Developing a model for rehabilitation in the home as hospital substitution for patients requiring reconditioning: a Delphi survey in Australia. BMC Health Serv Res. 2023;23(1):113.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Australasian Faculty of Rehabilitation Medicine (AFRM). Standards for the provision of Inpatient Adult Rehabilitation Medicine Services in Public and Private Hospitals. Sydney: The Royal Australasian College of Physicians; 2019.

    Google Scholar 

  20. Australasian Faculty of Rehabilitation Medicine (AFRM). Standards for the provision of rehabilitation medicine services in the ambulatory setting 2014. Sydney, NSW, Australia. 2014. Available from: https://www.racp.edu.au/docs/default-source/advocacy-library/ambulatory-standards.pdf.

  21. Australasian Rehabilitation Outcomes Centre (AROC). AROC Ambulatory Report (January 2021 - December 2021) 2021. Available from: https://documents.uow.edu.au/content/groups/public/@web/@chsd/@aroc/documents/doc/uow272207.pdf. 8 July 2022.

  22. The Independent Hospital Pricing Authority. National Efficient Price Determination 2021–2022 March 2021. Available from: https://www.ihacpa.gov.au/resources/national-efficient-price-determination-2021-22.

  23. NSW Health. Admission to Discharge Care Coordination. Policy Directive. PD2022_012 2022. Available from: https://www1.health.nsw.gov.au/pds/ActivePDSDocuments/PD2022_012.pdf. 24 April 2023.

  24. NSW Health. Remuneration and conditions. NSW public health system awards 2021. Available from: https://www.health.nsw.gov.au/careers/conditions/Pages/default.aspx. 21 November 2022.

  25. Insurance and care NSW (icare). Workers compensation premium rates 2022–2023 2022. Available from: https://www.icare.nsw.gov.au/-/media/icare/unique-media/employers/premiums/calculating-the-cost-of-your-premium-2022-2023/workers-compensation-premium-rates-2022-2023.pdf. 20 March 2023.

  26. Australian Institute of Health and Welfare. Hospital Resources 2018–19: Australian Hospital Statistics 2018–2019. Table 2.6. Available from: https://www.aihw.gov.au/getmedia/0f041ca3-081d-4f90-913b-4ddde10a5eec/Hospital-resources-2018-19-Tables.xlsx.aspx. 20 March 2023.

  27. IHACPA. National Efficient Price Determination 2023. Available from: https://www.ihacpa.gov.au/health-care/pricing/national-efficient-price-determination. 7 December 2023.

  28. Australian Bureau of Statistics. Regional population 2021. Available from: https://www.abs.gov.au/statistics/people/population/regional-population/2021. 28 June 2022.

  29. Poulos CJ. Evaluating inpatient public rehabilitation in Australia using a utilization review tool developed in North America. J Rehabil Med. 2010;42:246–53.

    Article  PubMed  Google Scholar 

  30. Australian Government. Transition Care Program Guidelines. Updated October 2022. In: Department of Health and Aged Care, editor. Canberra: Australian Government; 2022.

  31. Department of Health and Aged Care. Flexible care subsidy for the Short-Term Restorative Care (STRC) Programme Canberra: Australian Government; 2021. Available from: https://www.health.gov.au/initiatives-and-programs/short-term-restorative-care-strc-programme/funding-for-the-short-term-restorative-care-strc-programme/flexible-care-subsidy-for-the-short-term-restorative-care-strc-programme.

  32. KPMG. Review of the Transition Care Program2019. Available from: https://www.health.gov.au/sites/default/files/documents/2019/12/review-of-the-transition-care-programme-final-report_0.pdf.

  33. Leff B, Burton L, Mader SL, Naughton B, Burl J, Inouye S, et al. Hospital at home: feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients. Ann Intern Med. 2005;143(11):798–808.

    Article  PubMed  Google Scholar 

  34. Caplan GA, Sulaiman NS, Mangin DA, AimoninoRicauda N, Wilson AD, Barclay L. A meta-analysis of “hospital in the home.” Med J Aust. 2012;197(9):512–9.

    Article  PubMed  Google Scholar 

  35. Closa C, Mas M, Santaeugènia SJ, Inzitari M, Ribera A, Gallofré M. Hospital-at-home integrated care program for older patients with orthopedic processes: An efficient alternative to usual hospital-based care. J Am Med Dir Assoc. 2017;18(9):780–4.

    Article  PubMed  Google Scholar 

  36. Macintyre CR, Ruth D, Ansari Z. Hospital in the home is cost saving for appropriately selected patients: a comparison with in-hospital care. Int J Qual Health Care. 2002;14(4):285–93.

    Article  PubMed  Google Scholar 

  37. Dow B, McDonald J. The invisible contract: shifting care from the hospital to the home. Aust Health Rev. 2007;31(2):193–202.

    Article  PubMed  Google Scholar 

  38. Dow B, Black K, Bremner F, Fearn M. A comparison of a hospital-based and two home-based rehabilitation programmes. Disabil Rehabil. 2007;29(8):635–41.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank our Delphi survey participants for their time and valuable contributions.

Funding

This study was funded by the Medibank Better Health Foundation. The funding body had no role in the design of the study; collection, analysis, interpretation of data; or in the writing of the manuscript.

Author information

Authors and Affiliations

Authors

Contributions

All authors (RGP, AMDC, DRH, KNW, SGF, T-AN, FK, F-CU, TA, JTC, CMCO, CJP) contributed to the conception or design of the research, participant recruitment, and the development of the Delphi questionnaires. RGP, AMC, KNW and CJP oversaw the management of the study. DRH undertook the cost modelling based on Delphi survey data prepared by RGP. All authors contributed to the assumptions which informed the cost modelling, and critically revised the initial draft of the manuscript which was prepared by RGP. The final manuscript has been approved by all authors.

Corresponding author

Correspondence to Christopher J. Poulos.

Ethics declarations

Ethics approval and consent to participate

The project was approved by the St Vincent’s Hospital Research Ethics Committee (2021/ETH01105) and was carried out in accordance with the National Statement on Ethical Conduct in Human Research (2007). All study participants provided informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Methodology for deriving the modelled number of substitutable episodes per annum.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Poulos, R.G., Cole, A.M.D., Hilvert, D.R. et al. Cost modelling rehabilitation in the home for reconditioning in the Australian context. BMC Health Serv Res 24, 151 (2024). https://doi.org/10.1186/s12913-023-10527-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12913-023-10527-2

Keywords